Apnimed, Inc. (APMD) vs Gyre Therapeutics, Inc. (GYRE)

A side-by-side comparison of Apnimed, Inc. and Gyre Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APMD

Apnimed, Inc.

$866M

$21.75HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

GYRE

Gyre Therapeutics, Inc.

$819M

$7.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — APMD vs GYRE

growth of $100 · dividends reinvested · last 1y

APMD +35.9% (+35.9%/yr)GYRE +22.3% (+22.3%/yr)APMD compounded faster over this window

APMD GYRE

Metrics side by side

Total return (annualized)

Metric	APMD	GYRE
Total return (1Y)	N/A	0.14%
Total return CAGR (3Y)	N/A	4.45%
Total return CAGR (5Y)	N/A	-0.34%
Total return CAGR (10Y)	N/A	-14.92%

APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APMD analysis Full GYRE analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.